February 2012

January February 2012 Supplement

Articles

NEWS

Business of Retina
Retina on Wall Street

Pennsylvania Avenue Updates

Clinical Trials for the Retina Specialist

Fellow's Focus

  • Turning Ideas Into Products

    Experts share insights on taking the napkin sketch through the patent process to reality. Part 1 of 2 parts.
    With EMMETT T. CUNNINGHAM JR., MD, PHD, MPH; PAUL E. TORNAMBE, MD; AND EUGENE DE JUAN JR., MD

RETINA SURGERY

ONCOLOGY

COVER STORIES

DIABETIC RETINOPATHY: CASE REPORT

View All News >
News
Allegro Begins Second Study Using Integrin Peptide Therapy

Allegro Ophthalmics LLC has announced the commencement of its second human study using integrin peptide therapy for the treatment of vascular eye diseases such as wet AMD and diabetic macular edema (DME), according to a compan... more >

News
Bausch + Lomb, Topcon Partner to Deliver Products to Retinal Surgeons in Japan

The Japanese subsidiaries of Bausch + Lomb and Topcon Corp. have announced a collaboration to copromote their ophthalmic surgical products in Japan. Included in the agreement is the introduction of the Stellaris PC (Procedural... more >

News
Brain Cortex Size May Be Linked to Development of Cognitive Decline

Thinning of some regions of the brain’s cortex, as detected by MRI, may be associated with an increased risk of cognitive decline development, according to a study in emNeurology/em.sup1/sup Bradford C. Dickerson, MD, of Mas... more >

News
Embryonic Stem Cell Therapy Was Safe, Improved Vision in 2 Patients With Macular Degeneration

Subretinal transplantation of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) cells showed no adverse safety issues and yielded slight visual improvements in 2 patients with macular degeneration, acco... more >

Advertisement

TOP 5 ARTICLES FROM FEBRUARY 2012